Susceptible Microorganisms ABSSSI MSSA MRSA S. pyogenes S. agalactiae S. dysgalactiae S. anginosus group E. faecalis (vancomycin-susceptible strains) 98% benefit approval with the Dalvance Connects® and included both covered cases and covered with restrictions cases. " Covered with restrictions " typically means a prior authorization, proof of medical necessity, or step edit may be required. program*2 * Benefit verifications coverage was based on a total of 3602 patients from 01/01/2023 to 11/05/2023, as reported by Dalvance Connects® A SINGLE DOSE of DALVANCE provides a full course of therapy,1 helping your patients avoid hospitalization for ABSSSI treatment